posticon FEBS J Poster Prizes

Published: Thursday, 12 January 2017 12:44 Print Email

Two poster prizes (€200 each) will be sponsored by The FEBS Journal. For tips on designing and presenting a prize-winning poster, check out this July 2016 FEBS News piece entitled "What makes a good conference poster?" (page 9 in the PDF).


FEBS J Poster Prizes Awardees of FEBS-MPST 2017


1) P12: Increased plasma hyaluronan levels correlate with the severity of Dengue virus infection - characterization of the molecular mechanisms involved

Chun-Yu Lin1,2,3, Konstantinos Kolliopoulos1, Chung-Hao Huang2, Jyrki Tenhunen4, Jaap van der Heijden4, Yan-Shuang Li1, Carl-Henrik Heldin1, Yen–Hsu Chen2* and Paraskevi Heldin1,3*

1Ludwig Institute for Cancer Research, Science for Life Laboratory, Uppsala University, Box 595, SE-751 24 Uppsala, Sweden

2School of Medicine, Graduate Institute of Medicine, Sepsis Research Center, Center for Dengue FeverControl and Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

3Dept. of Medical Biochemistry and Microbiology, Uppsala University, Box 582, SE-751 23 Uppsala, Sweden

4Anesthesiology and Intensive Care, Dept. of Surgical Sciences, Uppsala University Hospital,

Uppsala University, Akademiska sjukhuseting 70 1 tr, 751 85 Uppsala, Sweden


2) P52: Complement inhibitor CSMD1 acts as a tumor suppressor in breast cancer by interacting with extracellular matrixreceptor EGFR

Chrysostomi Gialeli1, Safia Guleed1, Michael Bartoschek2, Matthias Mörgelin3, Petter Storm4, Kristian Pietras2and Anna M. Blom1

1Department of Translational Medicine, Lund University, Malmö, Sweden

2Translational Cancer Research, Medicon Village, Lund, Sweden

3Colzyx AB, Medicon Village, Lund, Sweden

4Department of Clinical Sciences Malmö, Division of Diabetes and Endocrinology, Lund University,Malmö, Sweden

posticon ISMB International Travel grants

Published: Wednesday, 15 April 2015 07:16 Print Email


ISMB will fund 4 International Travel grants of €400 each to help young scientists participate in the FEBS-MPST2017.

According to the current procedure for ISMB travel grants, applicants should apply directly to the ISMB for these awards. Full details can be found on the ISMB web site

The travel grants are for PhD students and postdocs up to 5 years post PhD. Grants are for international travel only and will be awarded on the basis of scientific excellence and relevance to matrix biology. The awardees are members of the ISMB and have not recently received a travel grant funded by ISMB. 

To apply for a travel grant, applicants should send their application to the ISMB secretary, including a letter giving details of the meeting, as well as the abstract of their poster/short talk, their curriculum vitae and list of publications.

The applicants for the ISMB International Travel grants should also submit their abstract and the respective Application Form to the Course organizers following the dates given in the General course info.

Deadline for International Travel Awards application: April 1st, 2017

posticon Young Investigator Awards

Published: Tuesday, 22 July 2014 10:01 Print Email

All abstracts with graduate students or postdoctoral fellows as first authors that not received a YTF are subject to scientific evaluation by selected members. The best 3 abstracts will receive the "FEBS-MPST2017 Young Investigator Award" at the end of the course. Each award will be financed with 200€. To be eligible for this award, individuals should also apply with an abstract, a curriculum vitae (one page) and one letter of recommendation. The candidates should include with the application their full address, phone and fax numbers, their e-mail address and an I.D. photo.

The young investigator awards are sponsored by Pharmaceutical firms, lab suppliers, and Publishers.

Deadline for Young Investigator Awards application: February 15th, 2017


YIA Awardees of FEBS-MPST 2017


1) P57: Unraveling silent pathologic al states by decoding their unique extracellular matrix signature in intestinal inflammation

Elee Shimshoni1, Ran Afik1, Anjana Shenoy 2, Miri Adler 3, Luca Puricelli 4, Alessandro Podestà4, Tamar Geiger2, Paolo Milani4, Uri Alon3 and Irit Sagi1

1Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel

2 Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine,

Tel Aviv University, Tel Aviv-Yafo, Israel

3Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

4CIMAINA and Department of Physics, Universitΰ degli Studi di Milano, Milano, Italy


2) P36: Lack of the extracellul ar matrix proteoglycan lumican in mice exacerbates left ventricular dilatation and contractile dysfunction upon pressure overload

Mohammadzadeh N.1,2, Lunde IG.1,2,3, Andenæs K.1,2, Strand M.E.1,2, Aronsen J.M.1,4, Skrbic B.1,2,5, Marstein H.S.1,2, Bandlien C.1,2,5, Nygård S.1,2, Sjaastad I.1,2, Chakravarti S. 6, Christensen G.1,2, Engebretsen K.V.1,2,5, Tønnessen T.1,2,5

1Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway

2 Center for Heart Failure Research, University of Oslo, Norway

3Department of Genetics, Harvard Medical School, Boston, MA, USA

4Bjørknes College, Oslo, Norway

5Department of Cardiothoracic Surgery, Oslo University Hospital Ullevεl, Norway

6Department of Medicine, Johns Hopkins University, Baltimore, USA


3) P61: Towards the generation of an animal model of chondrodysplasia with joint dislocations gPAPP type

R. Costantini1, L. Monti1, C. Paganini1, Stephan Sonntag2, A. Forlino1, A. Rossi1

1Dept. Molecular Medicine, Unit of Biochemistry, University of Pavia, Italy

2PolyGene AG, Rümlang, Switzerland

posticon footer

Published: Friday, 23 November 2012 14:11 Print Email

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.